Clinical Trials Network Helderberg

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)2 trials
• Rheumatoid arthritis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Not yet recruiting2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Hoffmann-La Roche2 trials
• Boehringer Ingelheim1 trial
• PTC Therapeutics1 trial

Running trials

• Recruiting

  Study of PTC844 in Participants With Active Rheumatoid Arthritis

  NCT07779616· Phase 2· PTC Therapeutics· Source

  Contact: Gareth Tarr (principal investigator)

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

  NCT07598396· Phase 2· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

  NCT04963296· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)1 recruiting
• Rheumatoid arthritis1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting